PROGRAMME KEYNOTES
Brian
Clark
Ohio University
Athens, OH USA
Neuromuscular changes with aging and sarcopenia
Charlotte
A.Peterson
University of Kentucky
Lexington, KY USA
Muscle cell regenerative capacity and aging
Linda
Fried
Columbia University
New York, NY USA
Frailty: What's been done and what needs doing
Cornell
Sieber
F. Alexander-University
Nuremberg, Germany
Nutrition, sarcopenia and frailty
Nathan
Lebrasseur
Mayo Clinic
Rochester, NY USA
Myostatin and other biomarkers of sarcopenia
Joshua M Hare
Longeveron, Miami, FL USA
Stems cells for frailty : rational, biological and clinical impact
SYMPOSIUM HIGHLIGHTS INCLUDE
WHO-ESCEO Symposium
“Assessment of Physical Performance
in daily clinical practice”
Outcomes of an Expertsconsensus meeting organized
by the European Society for Clinical and Economic
Aspects of Osteoporosis, Osteoarthritis
and Musculoskeletal Diseases (ESCEO)
under the auspices of the World Health Organization”
“Osteoporosis and sarcopenia :
Two diseases or one ?”
Lifetime course of muscle and bone wasting
C.Cooper, Southampton, UK
Role of nutrition and physical exercise in the prevention of bone and muscle wasting
R. Rizzoli, Geneva, Switzerland
What can we learn from osteoporosis to get a treatment against sarcopenia approved?
JY Reginster, Liège, Belgium
The ENRGISE pilot trial
to avert inflammation, mobility loss,
and frailty: early results
Stephen Kritchevsky
Wake Forest School of Medecine,
Winston-Salem, NC USA
PRELININARY PROGRAM
ONLINE ON NOVEMBER 2017
Call for abstracts: Symposium/Oral communication/Poster: Submission deadline: November 19, 2017
